NVCR Q4 2022 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$128M-3.6% YoY

Gross Profit

$100M77.5% margin

Operating Income

-$43M-33.5% margin

Net Income

-$37M-29.0% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-2.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$10M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$750M

Stockholders' Equity

$441M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$128M	$133M	-3.6%
Gross Profit	$100M	$104M	-3.8%
Operating Income	-$43M	-$23M	-83.7%
Net Income	-$37M	-$26M	-41.0%

Geographic Segments

UNITED STATES

$99M81%

GERMANY

$10M8%

JAPAN

$8M7%

CHINA

$5M4%